The DOI matches its Crossref record; 47 of the 49 references it cites were found in a registry or an index.
Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
Open accessAbstract
Cancer cells consume large quantities of nutrients and maintain high levels of anabolism. Recent studies revealed that various oncogenic pathways are involved in modulation of metabolism. Nrf2, a key regulator for the maintenance of redox homeostasis, has been shown to contribute to malignant phenotypes of cancers including aggressive proliferation. However, the mechanisms with which Nrf2 accelerates proliferation are not fully understood. Here, we show that Nrf2 redirects glucose and glutamine into anabolic pathways, especially under the sustained activation of PI3K-Akt signaling. The active PI3K-Akt pathway augments the nuclear accumulation of Nrf2 and enables Nrf2 to promote metabolic activities that support cell proliferation in addition to enhancing cytoprotection. The functional expansion of Nrf2 reinforces the metabolic reprogramming triggered by proliferative signals.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, NRF2 steers glucose to anabolic cancer metabolism and prevents oxidation of multiple translational factors to augment protein output [15,16].”
From NRF2 Activation Confers Resistance to eIF4A Inhibitors in Cancer Therapy (2021) · cites this paper as [16]
In the citing paper
“The aberrant activation of Nrf2 in cancer cells leads to increased expression of Glucose-6-phosphate dehydrogenase (G6PD), transketolase (TKT), 6-phosphogluconate dehydrogenase (PGD), and other metabolic enzymes promoting glutamine and glucose metabolism in pentose phosphate pathway (PPP) and increasing synthesis of amino acids participating in metabolic reprogramming required for cell prol”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Mitsuishi et al. 2012
Citations
Cites
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6943 · Cited by 3,999
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
Engelman, J. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2664 · Cited by 2,445
Tumor cell metabolism: cancer's Achilles' heel
Kroemer, G., & Pouyssegur, J. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.05.005 · Cited by 2,337
Regulation of glutathione synthesis
Lu, S. C.-L. (2008) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2008.05.005 · Cited by 2,131
Activation of a metabolic gene regulatory network downstream of mTOR complex 1
Düvel, K., Yecies, J. L., Menon, S., Raman, P., Lipovsky, A. I., Souza, A. L., Triantafellow, E., Ma, Q., Gorski, R., Cleaver, S., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.06.022 · Cited by 2,020
TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis
Bensaad, K., Tsuruta, A., Selak, M. A., Vidal, M. N. C., Nakano, K., Bartrons, R., Gottlieb, E., & Vousden, K. H. (2006) · Cell · doi:10.1016/j.cell.2006.05.036 · Cited by 2,019
Flagged first, then by citations
2 of the 49 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 901–1,000 of 1,000
Interplay of MKP-1 and Nrf2 drives tumor growth and drug resistance in non-small cell lung cancer
Wang, H., Liu, K., Chi, Z., Zhou, X., Ren, G., Zhou, R., Li, Y., Tang, X., & Wang, X. J. (2019) · Aging · doi:10.18632/aging.102531 · Cited by 16
“Besides regulating cytoprotective genes, Nrf2 induces the expression of metabolic genes, including glucose-6-phosphate dehydrogenase (G6PD), isocitrate dehydrogenase 1 (IDH1), phosphogluconate dehydrogenase (PGD), phosphoribosyl pyrophosphate amidotransferase (PPAT), methylenetetrahydrofolate dehydrogenase 2 (MTHFD2),…”
BackgroundOh, C., Ha, M., Han, M., et al. (2020) · Hematological Oncology · doi:10.1002/hon.2728 · Cited by 17
Tanshinone IIA inhibits osteosarcoma growth through modulation of AMPK-Nrf2 signaling pathway
Xie, Z., He, B., Jiang, Z., & Zhao, L. (2020) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2020.1772296 · Cited by 17
Nomura, N., Ito, C., Ooshio, T., Tadokoro, Y., Kohno, S., Ueno, M., Kobayashi, M., Kasahara, A., Takase, Y., Kurayoshi, K., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-81076-z · Cited by 19
The Role of NRF2 in Mycobacterial Infection
Matsuyama, M., Nonaka, M., Nakajima, M., Morishima, Y., Ishii, Y., & Hizawa, N. (2021) · Antioxidants · doi:10.3390/antiox10121861 · Cited by 17
Dimethyl fumarate ameliorates cisplatin-induced renal tubulointerstitial lesions
Sasaki, A., Koike, N., Murakami, T., & Suzuki, K. (2019) · Journal of Toxicologic Pathology · doi:10.1293/tox.2018-0049 · Cited by 18
Ping, M., Li, G., Li, Q., Yang, F., Fan, T., Wu, J., Zhang, R., Zhang, L., Shen, B. Q., & Guo, J. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-07052-3 · Cited by 16
Arachidonic acid suppresses hepatic cell growth through ROS ‐mediated activation of transglutaminase
Qin, X., Lu, J., Cai, M., & Kojima, S. (2018) · FEBS Open Bio · doi:10.1002/2211-5463.12511 · Cited by 16
The Keap1-Nrf2 pathway: From mechanism to medical applications
Baird, L., & Yamamoto, M. P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-818606-0.00009-2 · Cited by 16
Self-citationCurrent Pathology Model of Pancreatic Cancer
Szymoński, K., Milian-Ciesielska, K., Lipiec, E. W., & Adamek, D. (2022) · Cancers · doi:10.3390/cancers14092321 · Cited by 15
Xi, C., Pang, J., Zhi, W., Chang, C., Siddaramappa, U., Shi, H., Horuzsko, A., Pace, B. S., & Zhu, X. (2023) · Blood · doi:10.1182/blood.2022018159 · Cited by 16
Claridge, B., Rai, A., Lees, J. G., Fang, H., Lim, S. Y., & Greening, D. W. (2023) · Journal of Extracellular Biology · doi:10.1002/jex2.125 · Cited by 16
“Significant downregulation of stress response related KEAP1-NFE2L2 pathway, and altered expression of antioxidant and ROS related proteins TKT (Xu et al., 2016), TXNDC9 (Zhou et al., 2020), MARCKS (Huber et al., 2022), and ATOX1 (Chen et al., 2015) suggested a disruption to the oxidative state of TGF β -CM-CF.”
BackgroundInfluentialEffects of Nrf2 deficiency on arsenic metabolism in mice
Wang, H., Zhu, J., Li, L., Li, Y.-F., Lv, H., Xu, Y., Sun, G., & Pi, J. (2017) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2017.11.001 · Cited by 16
“…heterodimerizes with small Maf proteins and binds to the antioxidant response element (ARE), which is present in the promoters of multi genes encoding antioxidant enzymes, phase II detoxification enzymes, drug transporters and metabolic enzymes etc. (Mitsuishi et al., 2012; Suzuki et al., 2013).”
BackgroundNrf2 and the Nrf2-Interacting Network in Respiratory Inflammation and Diseases
Carlson, J., Price, L., & Deng, H. (2020) · Progress in inflammation research · doi:10.1007/978-3-030-44599-7_3 · Cited by 17
Placental proteome in late‑onset of fetal growth restriction
Gęca, T., Stupak, A., Nawrot, R., Goździcka‐Józefiak, A., Kwaśniewska, A., & Kwaśniewski, W. M. (2022) · Molecular Medicine Reports · doi:10.3892/mmr.2022.12872 · Cited by 16
“PPP is one of the branches of glycolysis and serves a key role in meeting the cellular requirements of biosynthesis and antioxidant defense (101).”
BackgroundWu, J., Zhou, J., Chai, Y., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1172182 · Cited by 16
Айтбаев, К. А., Murkamilov, I. T., & Fomin, V. V. (2019) · Advances in Gerontology · doi:10.1134/s2079057019040027 · Cited by 16
RetractedThe Complex Roles of Redox and Antioxidant Biology in CancerPreprint
Hayashi, M., Okazaki, K., Papgiannakopoulos, T., & Motohashi, H. (2024) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041546 · Cited by 16
Self-citationBiological Marker Analysis as Part of the CIBERES-RTIC Cancer-SEPAR Strategic Project on Lung Cancer
Monsó, E., Montuenga, L. M., de Cos, J. S., et al. (2015) · Archivos de Bronconeumología · doi:10.1016/j.arbr.2015.05.005 · Cited by 15
Lv, J., Xie, M., Zhao, S., Qiu, W., Wang, S., & Cao, M. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02184-4 · Cited by 15
“In lung cancer cells, Nrf2 redirects glutamine and glucose metabolism to anabolic pathways via metabolic reprogramming, which benefits uncontrolled cancer cell proliferation [30].”
Metabolomics of oxidative stress: Nrf2 independent depletion of NAD or increases of sugar alcohols
Zhu, C., Gu, H., Jin, Y., Wurm, D., Freidhof, B., Lu, Y., & Chen, Q. M. (2022) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2022.115949 · Cited by 15
Genetic, metabolic and immunological features of cancers with NRF2 addiction
Kitamura, H., Takeda, H., & Motohashi, H. (2022) · FEBS Letters · doi:10.1002/1873-3468.14458 · Cited by 15
Self-citationRerouting the drug response: Overcoming metabolic adaptation in KRAS-mutant cancers
Moss, D., McCann, C. K., & Kerr, E. M. (2022) · Science Signaling · doi:10.1126/scisignal.abj3490 · Cited by 16
“Importantly, increased PPP and SSP metabolism—frequent events in KRASmutant cancers (5, 23)—can also inhibit therapeutic responses.”
BackgroundInfluentialFerroptosis: The functions of Nrf2 in human embryonic stem cells
Abraki, S. B., Karamali, F., & Nasr‐Esfahani, M. H. (2023) · Cellular Signalling · doi:10.1016/j.cellsig.2023.110654 · Cited by 16
Wang, Z., Liu, N., Yang, Y., & Tu, Z. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1349867 · Cited by 18
Targeting kelch-like (KLHL) proteins: achievements, challenges and perspectives
Zhou, Y., Zhang, Q., Zhao, Z., Hu, X., You, Q., & Jiang, Z. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116270 · Cited by 15
Yaylım, İ., Aru, M., Farooqı, A. A., Hakan, M. T., Buttari, B., Arese, M., & Saso, L. (2024) · Cancer Drug Resistance · doi:10.20517/cdr.2023.79 · Cited by 15
Baqader, N. O., Radulović, M., Crawford, M., Stoeber, K., & Godovac‐Zimmermann, J. (2014) · Journal of Proteome Research · doi:10.1021/pr500638h · Cited by 16
Therapeutic targets in the selective killing of cancer cells by nanomaterials
Akhtar, M. J., Ahamed, M., & Alhadlaq, H. A. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.03.020 · Cited by 15
Broutian, T. R., Jiang, B., Li, J., et al. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.01.012 · Cited by 15
“In this latter model, PIM1 increased translation of the transcription factor NFR2 and downstream regulators of ROS scavengers and metabolism, promoting cell survival [53].”
MethodOng, A. J. S., Saeidi, S., Kieu, N. H., Kim, S. J., Kim, D., Kim, S. H., Park, S., Cha, Y., Na, H., & Surh, Y. (2020) · Free Radical Research · doi:10.1080/10715762.2020.1761547 · Cited by 15
“Nrf2 has been found to directly bind to the ARE-region of PGD in A549 cells [23].”
BackgroundResultInfluentialCheng, H. S., Marvalim, C., Zhu, P., Law, D. C. L., Low, Z. Y. J., Chong, Y. K., Ang, B. T., Tang, C., & Tan, N. S. (2021) · Theranostics · doi:10.7150/thno.54741 · Cited by 15
“Coincidentally, PI3K/Akt pathway also acts as an activator of Nrf2 transcription and nuclear translocation to modulate redox homeostasis and enhance cancer survival during carcinogenesis [57, 58].”
BackgroundKalezic, A., Udicki, M., Srdić, B., Aleksic, M., Korać, A., Janković, A., & Korać, B. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101939 · Cited by 16
Integrated analysis of patients with KEAP1/NFE2L2/CUL3 mutations in lung adenocarcinomas
Jin, X., Zheng, Y., Chen, Z., Wang, F., Bi, G., Li, M., Liang, J., Sui, Q., Bian, Y., Hu, Z., et al. (2021) · Cancer Medicine · doi:10.1002/cam4.4338 · Cited by 15
Man, S., Chai, H., Qiu, P., et al. (2015) · Pathology - Research and Practice · doi:10.1016/j.prp.2015.09.011 · Cited by 15
Dikovskaya, D., Appleton, P. L., Bento‐Pereira, C., & Dinkova‐Kostova, A. T. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.8b00354 · Cited by 15
Ozone at low concentrations does not affect motility and proliferation of cancer cells in vitro
Costanzo, M., Romeo, A., Cisterna, B., Calderan, L., Bernardi, P., Covi, V., Tabaracci, G., & Malatesta, M. (2020) · European Journal of Histochemistry · doi:10.4081/ejh.2020.3119 · Cited by 15
The Impact of the Ubiquitin System in the Pathogenesis of Squamous Cell Carcinomas
Gatti, V., Bernassola, F., Talora, C., Melino, G., & Peschiaroli, A. (2020) · Cancers · doi:10.3390/cancers12061595 · Cited by 15
Xiaodi, E., Shao, D., Li, M., et al. (2023) · Poultry Science · doi:10.1016/j.psj.2023.102573 · Cited by 15
The complex role of NRF2 in cancer: A genomic view
Praslicka, B. J., Kerins, M. J., & Ooi, A. (2016) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2016.09.003 · Cited by 14
Mechanism of Endometrial Receptivity Affected by Fibroids
Sun, P., Zhang, C., Wang, W., & Ma, H.-G. (2024) · American Journal of Reproductive Immunology · doi:10.1111/aji.70022 · Cited by 15
Yang, Y., Deng, X., Li, W., Leng, Y., Xiong, Y., Wang, B., Gong, S., Yang, B., Yang, B., & Li, W. (2025) · Clinical Epigenetics · doi:10.1186/s13148-025-01861-9 · Cited by 14
“…Nrf2 shows that enhancing the nuclear accumulation of Nrf2 to a level can promote metabolic activities that support cell proliferation, enhancing the metabolic reprogramming triggered by proliferation signals, indicating a potential connection between ferropto-sis and metabolic reprogramming [59].”
Song, Y., Luengo-Gutierrez, L., Sági‐Kiss, V., Kong, G., Huang, H., Steinruecke, M., Zhou, L., Yuan, Z., Virgiliis, F. D., Pap, I. S., et al. (2026) · Cell · doi:10.1016/j.cell.2025.12.003 · Cited by 18
Du, L., Zhang, Y., Luo, J., He, C., Lang, J., & Cao, X. (2026) · Experimental Hematology and Oncology · doi:10.1186/s40164-025-00737-1 · Cited by 15
“NRF2 activation transcriptionally upregulates metabolic enzymes producing NADPH, which drives acetyl-CoA and SAM biosynthesis, enhancing substrate availability for acetyltransferases and methyltransferases in a feed-forward loop that amplifies ferroptosis resistance [195].”
Transcription Factor Nrf2 and Mitochondria – Friends or Foes in the Regulation of Aging Rate
Shilovsky, G. A., & Ashapkin, V. V. (2022) · Biochemistry (Moscow) · doi:10.1134/s0006297922120057 · Cited by 14
“By activating the PI3K/Akt signaling, Nrf2 promotes the expression of genes involved in the pentose phosphate pathway, de novo nucleotide synthesis, NADPH production, purine biosynthesis, and glutamine metabolism [72].”
BackgroundPan-cancer and single-cell analysis reveal the prognostic value and immune response of NQO1
Shen, L., Jiang, S., Yu, Y., Yang, H., Fang, Y., Tang, M., Zhu, R.-T., Xu, J., & Jiang, H. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1174535 · Cited by 14
“Genes transcribed by NRF2 facilitate the synthesis of glutamine (Mitsuishi et al., 2012).”
BackgroundUnique and overlapping roles of NRF2 and NRF1 in transcriptional regulation
Sekine, H., & Motohashi, H. (2023) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.23-106 · Cited by 14
Self-citationWu, C., Mao, G., Ji, X., et al. (2024) · Aquatic Toxicology · doi:10.1016/j.aquatox.2024.107230 · Cited by 14
Bae, T., & Kwak, M. (2024) · Journal of Cancer Prevention · doi:10.15430/jcp.24.021 · Cited by 15
Application of proteomics in the elucidation of chemical-mediated allergic contact dermatitis
Höper, T., Mußotter, F., Haase, A., Luch, A., & Tralau, T. (2017) · Toxicology Research · doi:10.1039/c7tx00058h · Cited by 14
Petersen, D. R., Saba, L. M., Sayin, V. I., Papagiannakopoulos, T. Y., Schmidt, E. E., Merrill, G. F., Orlicky, D. J., & Shearn, C. T. (2018) · PLoS ONE · doi:10.1371/journal.pone.0198139 · Cited by 14
Otsuki, A., Okamura, Y., Aoki, Y., Ishida, N., Kumada, K., Minegishi, N., Katsuoka, F., Kinoshita, K., & Yamamoto, M. P. (2020) · Molecular and Cellular Biology · doi:10.1128/mcb.00472-20 · Cited by 13
“and TALDO1, which encode thioredoxin reductase 1 (46) and transaldolase 1 (9),”
BackgroundSelf-citationSreedurgalakshmi, K., Srikar, R., & Rajkumari, R. (2020) · Cancer Gene Therapy · doi:10.1038/s41417-020-00256-7 · Cited by 16
Nuclear Receptor-Mediated Metabolic Reprogramming and the Impact on HR+ Breast Cancer
Hussein, S., Khanna, P., Yunus, N., & Gatza, M. L. (2021) · Cancers · doi:10.3390/cancers13194808 · Cited by 15
The Intricate Metabolism of Pancreatic Cancers
Camelo, F. S., & Le, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-65768-0_5 · Cited by 15
Wang, S., Trapani, G. D., & Tonissen, K. F. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106134 · Cited by 14
Hirose, W., Horiuchi, M., Li, D., Motoike, I. N., Zhang, L., Nishi, H., Taniyama, Y., Kamei, T., Suzuki, M., Kinoshita, K., et al. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.09.004 · Cited by 15
Self-citationLower urinary pH is useful for predicting renovascular disorder onset in patients with diabetes
Ogawa, S., Nako, K., Okamura, M., & Ito, S. (2015) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2015-000097 · Cited by 14
“Under IR conditions, the serum UA concentration rises because of the increased production of UA in the liver or adipose tissues and decreased renal excretion of UA (see online supplementary figure S2).(25) 28 The UA production is increased by AMP deaminase activation induced by fructokinase activated by hyperglycemia…”
BackgroundKawaharada, R., Nakamura, A., Takahashi, K., et al. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.04.032 · Cited by 14
The NADPH Oxidase Inhibitor Apocynin Suppresses Preneoplastic Liver Foci of Rats
Fuji, S., Suzuki, S., Naiki‐Ito, A., et al. (2017) · Toxicologic Pathology · doi:10.1177/0192623317710013 · Cited by 14
“In this study, the downregulation of Nrf2 was detected in the liver of apocynin-treated rats alongside decreased ROS generation; however, the activation of downstream pathways of Nrf2 such as PI3K and Akt, which regulate cell proliferation (Mitsuishi et al. 2012), was not significantly different among the groups.”
BackgroundMurthy, P., & Muggia, F. M. (2019) · ecancermedicalscience · doi:10.3332/ecancer.2019.904 · Cited by 19
Liu, Y., Deng, J., & Fan, D. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111925 · Cited by 14
Ji, S., Xiong, Y., Zhao, X., Liu, Y., & Yu, L. (2019) · Oncology Letters · doi:10.3892/ol.2019.10156 · Cited by 14
“Nuclear accumulation of Nrf2 and binding to AREs in tumor cells results in increased gluta‐ thione levels, leading to upregulation of associated detoxifying enzymes and drug efflux pump genes, metabolic disorder of tumor cells and faster proliferation (43,44), further suggesting that Nrf2 serves as an oncogene to prom…”
BackgroundThe pentose phosphate pathway (PPP) in the glioma metabolism: A potent enhancer of malignancy
Trejo‐Solís, C., Escamilla-Ramírez, Á., Gómez‐Manzo, S., et al. (2025) · Biochimie · doi:10.1016/j.biochi.2025.01.013 · Cited by 13
Soutto, M., Zhang, X., Bhat, N. S., Chen, Z., Zhu, S., Maacha, S., Genoula, M., El-Gazzaz, O., Peng, D., Lu, H., et al. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102998 · Cited by 13
“NRF2 signature [49] was significantly enriched in FGFR4 high expression samples.”
BackgroundThiel, A., Drews, F., Pirritano, M., Schumacher, F., Michaelis, V., Schwarz, M., Franzenburg, S., Schwerdtle, T., Michalke, B., Kipp, A. P., et al. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103290 · Cited by 13
“Across various cancer cell lines, it was observed that Nrf2 activation heightened the dependency on exogenous glutamine, primarily directed towards GSH synthesis [47,48].”
BackgroundSánchez-Ortega, M., Garrido, A., Cirauqui, C., Sanz-Gonzalez, L., Hernández, M. C., González-Garcı́a, A., Obregon, K., Ferrer, I., Paz-Ares, L., & Carrera, A. C. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103305 · Cited by 14
Li, G., Li, H., Wang, P., et al. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-024-01958-3 · Cited by 13
“It is reported that lacking of TALDO1 is related to various of clinical symptoms, including coagulopathy, liver dysfunction and tumor [33], and high levels of TALDO1 have been found in various tumors [34].”
Fayed, H. M., Asaad, G. F., Elbaset, M. A., Sharaf, O. A., Mahmoud, S. S., Amin, M. M., El‐Gendy, Z. A., Ibrahim, F. A., Abdelgayed, S. S., & Abdel-Rahman, R. F. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04098-8 · Cited by 13
“Furthermore, Nrf2 promotes intermediate metabolism by means of glutaminolysis (Romero et al. 2017), which leads to an imbalance in metabolic activities, including nucleotide (Mitsuishi et al. 2012) and amino acid biosynthesis (DeNicola et al. 2015).”
Waku, T., & Kobayashi, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312686 · Cited by 12
“NRF2 also activates genes encoding enzymes for glutaminolysis, shifting the metabolic flux of glutamine to the glutathione synthesis pathway [14,15].”
BackgroundMao, Z., Zhong, L., Zhuang, X., Liu, H., & Peng, Y. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/3988916 · Cited by 13
“*is metabolic change is a hallmark of cancer cells [41].”
BackgroundChu, X., Zhong, L., Dan, W., Wang, X., Zhang, Z., Liu, Z., Lu, Y., Shao, X., Zhou, Z., Chen, S., et al. (2023) · Cellular Signalling · doi:10.1016/j.cellsig.2023.110626 · Cited by 13
Yuki, H., Kamai, T., Murakami, S., Higashi, S., Narimatsu, T., Kambara, T., Betsunoh, H., Abe, H., Arai, K., Shirataki, H., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25322 · Cited by 13
“They also stated that activation of the PI3K-Akt pathway augments nuclear accumulation of Nrf2 and supports cell proliferation, as well as enhancing cytoprotection, indicating that Nrf2 activation promotes metabolic reprogramming triggered by proliferative signals [11].”
BackgroundTaira, J., Miyazato, H., & Ueda, K. (2018) · Marine Drugs · doi:10.3390/md16100347 · Cited by 13
Hori, R., Yamaguchi, K., Sato, H., Watanabe, M., Tsutsumi, K., Iwamoto, S., Abe, M., Onodera, H., Nakamura, S., & Nakai, R. (2019) · Cancer Medicine · doi:10.1002/cam4.1949 · Cited by 13
Systematic Identification of Multi Omics-based Biomarkers in KEAP1 Mutated TCGA Lung Adenocarcinoma
Namani, A., Zheng, Z.-H., Wang, X. J., & Tang, X. (2019) · Journal of Cancer · doi:10.7150/jca.35489 · Cited by 13
“Seminal studies on NRF2 pathway revealed its specific role in metabolic reprogramming [9], carbon metabolism [10], serine biosynthesis [11] in Ivyspring”
BackgroundGenetic activation of Nrf2 reduces cutaneous symptoms in a murine model of Netherton syndrome
Muzumdar, S., Koch, M., Hiebert, H., Bapst, A. M., Gravina, A., Bloch, W., Beer, H., Werner, S., & Schäfer, M. (2020) · Disease Models & Mechanisms · doi:10.1242/dmm.042648 · Cited by 14
“A large number of additional Nrf2 target genes have been described; for example, genes involved in the unfolded protein response, in the formation of atherosclerotic plaques, in purine biosynthesis (Harada et al., 2012; Meakin et al., 2014; Mitsuishi et al., 2012; Rolfs et al., 2015; Tonelli et al., 2018) and in extra…”
BackgroundMeskers, C. J. W., Frańczak, M., Smolenski, R. T., Giovannetti, E., & Peters, G. J. (2022) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2022.2049234 · Cited by 13
“Furthermore, oncogenic pathways such as EGFR-mediated signaling have been shown to increase activity of enzymes in the PPP [6], and G6PD, 6PGD, TKT, and TALDO can be upregulated by NRF-2 via PIK3/Akt-mediated signaling [4,13].”
BackgroundNrf2 in Host Defense: Over the Rainbow
Cho, H., Kwak, M., & Pi, J. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/975839 · Cited by 13
Metabolic Phenotypes, Dependencies, and Adaptation in Lung CancerPreprint
DeNicola, G. M., & Shackelford, D. B. (2021) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a037838 · Cited by 13
Advances in targeting glycogen synthase kinase 3β for diabetes therapy
Wang, F., Li, Y., Bai, L., Xiao, W., Zhong, L., & Shi, J. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.109051 · Cited by 14
Xi, C., Pang, J., Barrett, A., Horuzsko, A., Ande, S., Mivechi, N. F., & Zhu, X. (2023) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-22-0935 · Cited by 12
Wang, J., Wang, H., Gao, M., Zhang, Y., Zhang, L., Huang, D., Tu, K., & Xu, Q. (2023) · APOPTOSIS · doi:10.1007/s10495-023-01875-9 · Cited by 14
“The synthesis of GSH involves two ATPdemanding steps: the formation of γ-glutamylcysteine from glutamate and cysteine, and the production of GSH from γ-glutamylcysteine and glycine [59].”
BackgroundInfluentialTanaka, I., Koyama, J., Itoigawa, H., Hayai, S., & Morise, M. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1249237 · Cited by 13
“Activation of NRF2 signaling resulting from KEAP1 inactivation promotes glucose and Gln metabolism toward the anabolic pathway through phosphatidylinositol 3’-kinase/protein kinase B signaling (112).”
BackgroundChen, L., Chu, Y., Ye, Z., Gu, S., Hu, Y., He, J., & Shen, Z. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1337129 · Cited by 13
The Role of NRF2 in Trinucleotide Repeat Expansion Disorders
Chang, K., & Chen, C. (2024) · Antioxidants · doi:10.3390/antiox13060649 · Cited by 12
Chen, S.-Y., Xu, H. Z., Qin, Y., He, T., Shi, R., Xing, Y.-R., Xu, J., Cong, R., Wang, M., Yang, J., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113478 · Cited by 12
Yang, J., Chen, D., He, Q., Chen, B., Pan, Z., Zhang, G., Li, M., Li, S., Xiao, J., Wang, H., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-83383-7 · Cited by 12
Joof, A. N., Bajinka, O., Zhou, Y., Ren, F., & Tan, Y. (2025) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-025-01821-3 · Cited by 16
HPD overexpression predicts poor prognosis in breast cancer
Wang, X., Shang, Y., Yang, L., et al. (2019) · Pathology - Research and Practice · doi:10.1016/j.prp.2019.152524 · Cited by 12
Zhou, J., Zhang, X., Tang, H., Yu, J., Zu, X., Xie, Z., Yang, X., Hu, J., Tan, F., Li, Q., et al. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.02.028 · Cited by 12
Nrf2-Keap1 Activation, A Promising Strategy in the Prevention of Cancer
Ojo, O. A., Ajiboye, B. O., Fadaka, A. O., Taro, P., & Shariati, M. A. (2016) · Free Radicals and Antioxidants · doi:10.5530/fra.2017.1.1 · Cited by 12
“• Shows ability to slow progression of and ‘kill’ cancer cell (Mitsuishi et al., 2012).”
BackgroundVoicu, S. N., Balaș, M., Stan, M. S., Trică, B., Șerban, A. I., Stanca, L., Hermenean, A. O., & Dinischiotu, A. (2019) · Materials · doi:10.3390/ma12071026 · Cited by 12
“One of these mediates the transcription of components of the pentose phosphate pathway that generates NADPH, which is an important reducing molecule in the framework of the antioxidant system [43].”
BackgroundPanda, H., Keleku-Lukwete, N., Kuga, A., Fuke, N., Suganuma, H., Suzuki, M., & Yamamoto, M. P. (2019) · Experimental Hematology · doi:10.1016/j.exphem.2019.08.001 · Cited by 11
Self-citationMornata, F., Pepe, G., Sfogliarini, C., Brunialti, E., Rovati, G. E., Locati, M., Maggi, A. C., & Vegeto, E. (2020) · Pharmacology Research & Perspectives · doi:10.1002/prp2.638 · Cited by 12
Simon‐Molas, H., Sánchez‐de‐Diego, C., Navarro‐Sabaté, À., Castaño, E., Ventura, F., Bartrons, R., & Manzano, À. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031905 · Cited by 13
“Constitutive activation of NRF2 is common in malignant cells regardless of ROS levels [16,17].”
BackgroundOgawa, S., Takiguchi, J., Shimizu, M., et al. (2016) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.239.103 · Cited by 12
Choe, J. H., Mazambani, S., Kim, T. H., & Kim, J. (2021) · Cells · doi:10.3390/cells10030606 · Cited by 14
“Furthermore, Nrf2 has been demonstrated to directly promote the PPP, nucleotide synthesis, NADPH production, and glutamine metabolism, especially in conjunction with active PI3K/AKT signaling, which promotes the nuclear accumulation of Nrf2 [157].”
BackgroundInfluentialMondal, S., Das, S., Mahapatra, P. K., et al. (2022) · Molecules · doi:10.3390/molecules27185819 · Cited by 11
Cui, Q., Wang, W., Namani, A., Wang, H., Hammad, A., Huang, P., Gao, Y., Elshaer, M., Wu, Y., Wang, X. J., et al. (2023) · Oncogene · doi:10.1038/s41388-023-02799-z · Cited by 11
“Similarly, through transcriptional transactivation, NRF2 directs anabolic metabolism by upregulating amino-acid metabolism, the pentose phosphate pathway, NADPH biosynthesis, nucleotide production, and fatty-acid oxidation, while suppressing NADPH‐consuming fatty-acid synthesis [9, 24, 25].”
Background
Metadata
- Authors
- Mitsuishi, Y., Taguchi, K., Kawatani, Y., Shibata, T., Nukiwa, T., Aburatani, H., Yamamoto, M., & Motohashi, H.
- Affiliations
- Tohoku University (JP)
- National Cancer Center Research Institute (JP)
- Research Center for Advanced Science and Technology, The University of Tokyo (JP)
- Corresponding author
- Yamamoto, Masayuki
- Motohashi, Hozumi
- ORCID
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2012-07
- Volume
- 22
- Issue
- 1
- Pages
- 66-79
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2053047691
- Semantic Scholar
- 280f3f56ddaa915842258eabcbeb792646ef42a7
- Cited by
- 1,395
- References
- 49
- Citations by year
- 2026: 72 · 2025: 85 · 2024: 97 · 2023: 112 · 2022: 132 · 2021: 126 · 2020: 131 · 2019: 108 · 2018: 103 · 2017: 101 · 2016: 89 · 2015: 85 · 2014: 76 · 2013: 63 · 2012: 12
- FWCI
- 30.36
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (23659166, 24249015, 24221011)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- Nrf2, tumor metabolic reprogramming, glucose metabolism, glutamine metabolism, anabolic metabolism, PI3K/Akt signaling, cell proliferation, redox homeostasis, cytoprotection
- MeSH terms
- Animals, Cell Division, Glucose, Glutamine, Mice, Transgenic, Neoplasms, Signal Transduction, Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins c-akt, NF-E2-Related Factor 2, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review